AU678970B2 - Universal coronavirus vaccine - Google Patents

Universal coronavirus vaccine

Info

Publication number
AU678970B2
AU678970B2 AU42404/93A AU4240493A AU678970B2 AU 678970 B2 AU678970 B2 AU 678970B2 AU 42404/93 A AU42404/93 A AU 42404/93A AU 4240493 A AU4240493 A AU 4240493A AU 678970 B2 AU678970 B2 AU 678970B2
Authority
AU
Australia
Prior art keywords
universal
coronavirus vaccine
coronavirus
vaccine
universal coronavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42404/93A
Other versions
AU4240493A (en
Inventor
Elaine V Jones
Sharon Klepfer
Timothy J Miller
Albert Paul Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU4240493A publication Critical patent/AU4240493A/en
Assigned to PFIZER INC. reassignment PFIZER INC. Amend patent request/document other than specification (104) Assignors: SMITHKLINE BEECHAM CORPORATION
Application granted granted Critical
Publication of AU678970B2 publication Critical patent/AU678970B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU42404/93A 1992-05-08 1993-05-07 Universal coronavirus vaccine Ceased AU678970B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88217192A 1992-05-08 1992-05-08
US882171 1992-05-08
PCT/US1993/004365 WO1993023421A1 (en) 1992-05-08 1993-05-07 Universal coronavirus vaccine

Publications (2)

Publication Number Publication Date
AU4240493A AU4240493A (en) 1993-12-13
AU678970B2 true AU678970B2 (en) 1997-06-19

Family

ID=25380027

Family Applications (2)

Application Number Title Priority Date Filing Date
AU42404/93A Ceased AU678970B2 (en) 1992-05-08 1993-05-07 Universal coronavirus vaccine
AU42410/93A Ceased AU678971B2 (en) 1992-05-08 1993-05-07 Compositions and methods for vaccination against coronaviruses

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU42410/93A Ceased AU678971B2 (en) 1992-05-08 1993-05-07 Compositions and methods for vaccination against coronaviruses

Country Status (5)

Country Link
EP (2) EP0640096A4 (en)
JP (2) JPH07508176A (en)
AU (2) AU678970B2 (en)
CA (2) CA2135201A1 (en)
WO (2) WO1993023421A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
CA2135201A1 (en) * 1992-05-08 1993-11-25 Timothy J. Miller Universal coronavirus vaccine
EP0640098B1 (en) * 1992-05-08 2002-10-09 Pfizer Inc. Canine coronavirus s gene and uses therefor
AU721367B2 (en) * 1993-02-26 2000-06-29 Wyeth Holdings Corporation Canine coronavirus vaccine from feline enteric coronavirus
EP0612532A3 (en) * 1993-02-26 1998-02-04 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
FR2724385B1 (en) * 1994-08-29 1996-12-13 Rhone Merieux FELINE INFECTIOUS PERITONITIS VACCINE.
AU6976296A (en) * 1995-09-15 1997-04-01 John A Howard Expression cassettes and methods for delivery of animal vaccines
US6033845A (en) * 1996-12-18 2000-03-07 Engene Biotechnologies Inc Specific diagnostic for feline infectious peritonitis antibodies
AU1408499A (en) * 1997-11-14 1999-06-07 Thomas P. Brown Compositions and methods to prevent turkey enteritis
WO2001009290A2 (en) * 1999-07-30 2001-02-08 Laboratorio Avi-Mex, S.A. De C.V. Avian infectious bronchitis virus serotype
FR2828405B1 (en) * 2001-08-09 2005-06-24 Virbac Sa ANTI-CORONAVIRUS VACCINE
AU2004259750A1 (en) * 2003-07-21 2005-02-03 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Soluble fragments of the SARS-CoV spike glycoprotein
US7605135B2 (en) * 2003-11-10 2009-10-20 The University Of Hong Kong Baicalin as a treatment for SARS infection
ITMI20111182A1 (en) * 2011-06-28 2012-12-29 Canio Buonavoglia VACCINE FOR CORONAVIRUS CANINO
WO2015143335A1 (en) * 2014-03-20 2015-09-24 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
CN113248576A (en) * 2020-02-12 2021-08-13 北京科兴中维生物技术有限公司 Nucleic acid vaccine for coronavirus and preparation method thereof
US20240009297A1 (en) * 2020-07-24 2024-01-11 Soligenix, Inc. Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses
CN113072626B (en) * 2021-04-25 2023-05-05 龙岩学院 Cat coronavirus S recombinant protein and preparation method thereof
CN113238048B (en) * 2021-05-11 2024-03-15 抗码(苏州)生物科技有限公司 Diagnostic markers and their use in differentiating between new coronavirus infection and new coronavirus inactivated vaccination
CN113861278B (en) * 2021-06-18 2022-08-05 国药中生生物技术研究院有限公司 Novel recombinant coronavirus RBD trimer protein vaccine capable of generating broad-spectrum cross-neutralization activity, and preparation method and application thereof
CN114478716B (en) * 2021-12-28 2024-05-28 梅州市人民医院(梅州市医学科学院) Polypeptide combination and application thereof in novel coronavirus antibody detection
CN114773487A (en) * 2022-05-31 2022-07-22 湖南大学 Influenza virus and novel coronavirus fusion recombinant protein vaccine immunogen and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666298B2 (en) * 1990-11-14 1996-02-08 Pfizer Inc. Recombinant feline coronavirus S proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
WO1991002752A1 (en) * 1989-08-22 1991-03-07 Veterinary Infectious Disease Organization Bovine coronavirus polypeptides and vaccines
CA2135201A1 (en) * 1992-05-08 1993-11-25 Timothy J. Miller Universal coronavirus vaccine
EP0640098B1 (en) * 1992-05-08 2002-10-09 Pfizer Inc. Canine coronavirus s gene and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666298B2 (en) * 1990-11-14 1996-02-08 Pfizer Inc. Recombinant feline coronavirus S proteins

Also Published As

Publication number Publication date
EP0640097A1 (en) 1995-03-01
WO1993023422A1 (en) 1993-11-25
CA2134898A1 (en) 1993-11-25
EP0640097A4 (en) 1997-01-15
EP0640096A1 (en) 1995-03-01
JPH08501931A (en) 1996-03-05
CA2135201A1 (en) 1993-11-25
EP0640096A4 (en) 1997-01-15
AU678971B2 (en) 1997-06-19
JPH07508176A (en) 1995-09-14
WO1993023421A1 (en) 1993-11-25
AU4240493A (en) 1993-12-13
AU4241093A (en) 1993-12-13

Similar Documents

Publication Publication Date Title
AU678970B2 (en) Universal coronavirus vaccine
AU3802493A (en) Surgical endoclip
AU5983994A (en) Universal implant abutment
AU3523693A (en) Coupling
AU4527093A (en) Deformable grip
AU3888793A (en) Novel medicament
AU1308495A (en) Influenza vaccine
AU2833392A (en) Shaft coupling
AU7973994A (en) Combination therapy for hiv infection
AU2252892A (en) Universal platform
AU3042892A (en) Rockbolt
AU3154395A (en) Contraceptive vaccine
AU3950193A (en) Cannula
AU2769595A (en) Contraceptive vaccine
AU4125793A (en) Medico-surgical devices
AU3791289A (en) Universal safety inoculation devices
AU4450696A (en) Enhanced immunogenic vaccine
AU6715094A (en) Recombinant vaccine
AU3461693A (en) Saddle-cloth
AU5512294A (en) Canine coronavirus vaccine from feline enteric coronavirus
AU2717792A (en) Shaft coupling
AU5959494A (en) Vaccines against sterols
AU4970193A (en) IPNV vaccine
AU4762993A (en) Keratometer
AU6409894A (en) Recognin vaccines

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired